¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive muscle relaxation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
¿µ¹® smooth muscle ÇÑ±Û ¹Î¹«´Ì±ÙÀ°, ÆòȰ±ÙÀ°
¼³¸í   
  ±ÙÀ° Áß¿¡¼­ °¡·Î¹«´Ì°¡ ¾ø´Â ±Ù. °¡·Î¹«´Ì±Ù¿¡ ´ëÀÀµÇ´Â ¸»ÀÌ´Ù. Ã´Ãßµ¿¹°¿¡¼­´Â ½ÉÀå±Ù ÀÌ¿ÜÀÇ ³»Àå±ÙÀº ¸ðµÎ°¡ ¹Î¹«´Ì±ÙÀÌ´Ù. ¸¹Àº ³»ÀåÀå±âÀÇ º®¿¡ ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, ´ë°³ µ¹¸²Ãþ°ú ¼¼·ÎÃþÀÇ µÎ ÃþÀ¸·Î ¹è¿­µÇ¾î ÀÖ´Ù. ¼ÒÈ­°üÀ̳ª ¿ä°ü °°Àº °ü¸ð¾çÀÇ ±¸Á¶¿¡¼­´Â ²ÞƲ¿îµ¿À» ÀÏÀ¸ÄÑ ³»¿ë¹°ÀÌ ¾Æ·¡·Î ³»·Á°¡°Ô Çϴ ÀÛ¿ëÀ» ÇÑ´Ù. Ç×¹®°ü, À§, ¿äµµ µî¿¡¼­´Â µ¹¸²ÃþÀÇ ±ÙÀ°À̠ƯÈ÷ µÎ²¨¿öÁ® ³»¿ë¹°ÀÌ ³»·Á°¡´Â °ÍÀ» Á¶ÀýÇϴ Á¶ÀÓ±ÙÀ°ÀÌ Çü¼ºµÇ¾î ÀÖ´Ù. Ç÷°ü¿¡´Â µ¹¸²Ãþ¸¸ ÀÖÀ¸¸ç, Ç÷°üÀ» ¼öÃàÇÏ¿© Ç÷¾×À» Áã¾îÂ¥´Â ÀÛ¿ëÀ» ÇÑ´Ù. ¶ÇÇÑ ÀÚÀ²½Å°æÀÇ Áö¹è¸¦ ¹ÞÀ¸¸ç, ¿ì¸®ÀÇ ÀÇÁö¿Í °ü°è¾øÀÌ ÀÛ¿ëÇÑ´Ù.
¿µ¹® voluntary muscle ÇÑ±Û ¼öÀDZÙ
¼³¸í   
  ÀÇÁöÀÇ ÈûÀ¸·Î ¿òÁ÷ÀÏ ¼ö Àִ ±ÙÀ°. °ñ°Ý±Ù ¿Ü¿¡ ÇǺΠ³»ÀÇ ÇDZÙ, °üÀýÁÖ¸Ó´Ï¿¡ ºÎÂøÇϰí Àִ °üÀý±Ù µîÀÌ ¿©±â¿¡ ¼ÓÇÑ´Ù. ¼öÀDZÙÀÇ ±Ù¼¶À¯¿¡´Â °¡·Î¹«´Ì°¡ ÀÖÀ¸¹Ç·Î °¡·Î¹«´Ì±ÙÀ̶ó°íµµ Çϳª, ½ÉÀå±ÙÀº °¡·Î ¹«´Ì°¡ À־ ¼öÀDZÙÀÌ ¾Æ´Ï¹Ç·Î ¼öÀDZٰú °¡·Î¹«´Ì±ÙÀº µ¿ÀǾî´Â ¾Æ´Ï´Ù. ¼öÀDZÙÀÇ ¿îµ¿Àº ¹Î¹«´Ì±Ùº¸´Ù ºü¸£´Ù. ¼öÀDZÙÀ̶ó Çصµ °ñ°Ý±Ù µîÀº ±ÙÀ°¹«¸®·Î¼­ ¿òÁ÷ÀÏ ¼ö ÀÖÀ¸³ª, °³°³ÀÇ ±ÙÀ°Àº µû·Îµû·Î ¸¶À½´ë·Î ¿òÁ÷À̰ԠÇÒ ¼ö ¾ø´Ù. ±Ó¹ÙÄû±ÙÀ°Àº »ç¶÷ÀÇ °æ¿ì ¹ßÀ°ÀÌ ³ªºü ¸¶À½´ë·Î ¿òÁ÷À̰ԠÇÏ±â ¾î·Æ´Ù. 
¿µ¹® facial muscle ÇÑ±Û ¾ó±¼±ÙÀ°
¼³¸í   
  ¾ó±¼ÀÇ ÇǺθ¦ ¿òÁ÷À̰í ÀÌ¿¡ ºÎÂøµÇ¾î Àִ ¾ó±¼½Å°æÀÇ °ø±ÞÀ» ¹Þ´Â ¼ö¸¹Àº ±ÙÀ°À» Æ÷ÇÔÇϴ ¾ó±¼Ç¥Á¤±ÙÀ̳ª ¸ð¹æ±Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • spin-spin relaxation time
    ½ºÇɽºÇÉÀ̿Ͻð£
  • acquired progressive lymphangioma
    ÈÄõÁøÇาÇÁ°üÁ¾
  • chronic progressive disciform granulomatosis
    ¸¸¼ºÁøÇà¿ø¹ÝÀ°¾ÆÁ¾Áõ
  • familial progressive hearing loss
    °¡Á·¼ºÁøÇ೭û
  • idiopathic progressive atrophoderma
    ¿øÀκҸíÁøÇàÇǺÎÀ§Ãà(Áõ)
  • progressive
    ÁøÇà-
  • progressive bulbar palsy
    ÁøÇà¼û³ú¸¶ºñ, ÁøÇ࿬¼ö¸¶ºñ
  • progressive cardiomyopathic lentiginosis
    ÁøÇà½É±Ùº´Èæ»öÁ¡Áõ
  • progressive case
    ÁøÇ༺¿¹
  • progressive deafness
    ÁøÇ೭û
  • progressive diaphyseal dysplasia
    ÁøÇ༺»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇ༺°ñ°£Çü¼ºÀÌ»ó
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive disseminated histoplasmosis
    ÁøÇàÆÄÁ¾È÷½ºÅäÇö󽺸¶Áõ
  • progressive external ophthalmoplegia
    ÁøÇà¹Ù±ù´«±ÙÀ°¸¶ºñ
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°, ÁøÇàºñ´ë°£Áú½Å°æ¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • facial muscle
    ¾ó±¼±ÙÀ°
  • gastrocnemius muscle
    ÀåµýÁö±Ù
  • gluteus muscle
    º¼±â±Ù, µÐ±Ù
  • hamstring muscle
    µÚ³Ò´Ù¸®±Ù
  • iliopsoas muscle
    ¾ûµ¢Ç㸮±Ù
  • involuntary muscle
    ºÒ¼öÀDZÙ, Á¦´ë·Î±Ù
  • levator ani muscle
    Ç×¹®¿Ã¸²±Ù
  • orbicularis oculi muscle
    ´«µÑ·¹±Ù
  • pectoralis major muscle
    Å«°¡½¿±Ù, ´ëÈä±Ù
  • pterygoid muscle
    ³¯°³±Ù
  • quadriceps femoris muscle
    ³Ò´Ù¸®³×°¥·¡±Ù, ´ëÅð»çµÎ±Ù
  • rectus femoris muscle
    ³Ò´Ù¸®°ðÀº±Ù
  • red muscle
    Àû»ö±ÙÀ°
  • skeletal muscle
    °ñ°Ý±Ù
  • smooth muscle
    ¹Î¹«´Ì±Ù, ÆòȰ±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relaxation rate
    ÀÌ¿ÏÀ²
  • relaxation state
    À̿ϻóÅÂ
  • relaxation suture
    À̿ϺÀÇÕ
  • relaxation training
    ÀÌ¿ÏÈÆ·Ã
  • spin lattice relaxation
    ½ºÇɰÝÀÚÇ®¸², ½ºÇɰÝÀÚÀÌ¿Ï
  • spin spin relaxation
    ½ºÇɽºÇÉÇ®¸², ½ºÇɽºÇÉÀÌ¿Ï
  • transverse relaxation
    °¡·ÎÃàÇ®¸², ȾÃàÀÌ¿Ï
  • spin lattice relaxation time
    ½ºÇɰÝÀÚÀ̿Ͻð£
  • spin spin relaxation time
    ½ºÇɽºÇÉÀ̿Ͻð£
  • thermal relaxation time
    ¿­À̿Ͻð£
  • acquired progressive lymphangioma
    ÈÄõÁøÇาÇÁ°üÁ¾
  • idiopathic progressive atrophoderma
    ¿øÀκҸíÁøÇàÇǺÎÀ§ÃàÁõ
  • neural progressive muscular atrophy
    ½Å°æÁøÇà±ÙÀ°À§Ãà
  • progressive spinal amyotrophy
    ÁøÇàô¼ö±ÙÀ°À§ÃàÁõ
  • chronic progressive disciform granulomatosis
    ¸¸¼ºÁøÇà¿ø¹ÝÀ°¾ÆÁ¾Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • T1 relaxation
    T1 ÀÌ¿Ï
  • T1 relaxation time
    T1 ÀÌ¿Ï ½Ã°£
  • T2 (spin spin) relaxation time
    T2(½ºÇɽºÇÉ) À̿Ͻð£
  • T2 relaxation time
    T2 ÀÌ¿Ï ½Ã°£
  • heat of relaxation
    À̿Ͽ­(ì¬èÐæð).
  • phase of relaxation
    À̿ϱâ(ì¬èÐÐï).
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
  • relaxation
    ÀÌ¿Ï
  • relaxation exercise
    À̿Ͽ¬½À
  • relaxation heat
    À̿Ͽ­(ì¬èÐæð).
  • relaxation of accommodaton
    Á¶ÀýÀÌ¿Ï
  • relaxation of stress
    ÀÀ·ÂÀÌ¿Ï(ëëæ³ì¬èÐ).
  • relaxation oscillation
    ÀÌ¿ÏÁøµ¿(ì¬èÐòÉÔÑ).
  • relaxation phase
    À̿ϻó(ì¬èÐßÓ).
  • relaxation property
    ÀÌ¿Ï ¼ºÁú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • longitudinal relaxation time
    Á¾Ãà ÀÌ¿Ï ½Ã°£
  • muscular relaxation
    ±ÙÀÌ¿Ï, ±ÙÀ°ÀÌ¿Ï.
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
  • phase of relaxation
    À̿ϱâ(ì¬èÐÐï).
  • proton relaxation
    ¾çÀÚ ÀÌ¿Ï
  • proton relaxation enhancement
    ¾çÀÚ ÀÌ¿Ï Áõ°­
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
  • receptive relaxation
    ¼ö¿ë¼º ÀÌ¿Ï(áôé»àõ ì¬èÐ).
  • relaxation
    ÀÌ¿Ï
  • relaxation exercise
    À̿Ͽ¬½À
  • relaxation heat
    À̿Ͽ­(ì¬èÐæð).
  • relaxation of accommodaton
    Á¶ÀýÀÌ¿Ï
  • relaxation of stress
    ÀÀ·ÂÀÌ¿Ï(ëëæ³ì¬èÐ).
  • relaxation oscillation
    ÀÌ¿ÏÁøµ¿(ì¬èÐòÉÔÑ).
  • relaxation phase
    À̿ϻó(ì¬èÐßÓ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Obliquus auricularis muscle
    ±Ó¹ÙÄûºø±Ù
    [¿¾ ¿ë¾î] À̰³»ç±Ù
  • Auricular pyramidal muscle
    ±Ó¹ÙÄûÇǶó¹Ô±Ù
    [¿¾ ¿ë¾î] À̰³Ãßü±Ù
  • Muscle fascicle
    ±ÙÀ°´Ù¹ß
    [¿¾ ¿ë¾î] ±Ù¼Ó
  • Muscle fiber
    ±ÙÀ°¼¶À¯
    [¿¾ ¿ë¾î] ±Ù¼¶À¯
  • Satellite cell of skeletal muscle
    ±ÙÀ°À§¼º¼¼Æ÷
    [¿¾ ¿ë¾î] ±ÙÀ§¼º¼¼Æ÷
  • Muscle layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Tracheal muscle
    ±â°ü±Ù
    [¿¾ ¿ë¾î] ±â°ü±Ù
  • Bronchial muscle
    ±â°üÁö±Ù
    [¿¾ ¿ë¾î] ±â°üÁö±Ù
  • Bronchoesophageal muscle
    ±â°üÁö½Äµµ±Ù
    [¿¾ ¿ë¾î] ±â°üÁö½Äµµ±Ù
  • Sulcus for flexor hallucis longus muscle
    ±ä¾öÁö±ÁÈû±ÙÈûÁÙ°í¶û
    [¿¾ ¿ë¾î] Àå¸ðÁö±¼±Ù°Ç±¸
  • Sulcus for peroneus longus muscle
    ±äÁ¾¾Æ¸®±ÙÈûÁÙ°í¶û
    [¿¾ ¿ë¾î] Àåºñ°ñ±Ù°Ç±¸
  • Bipennate muscle
    ±ê±ÙÀ°
    [¿¾ ¿ë¾î] ¿ì»ó±Ù
  • Deep transverse perineal muscle
    ±íÀº»ô°¡·Î±Ù
    [¿¾ ¿ë¾î] ½ÉȸÀ½È¾±Ù
  • Coccygeus muscle
    ²¿¸®±Ù
    [¿¾ ¿ë¾î] ¹Ì°ñ±Ù
  • Spiral muscle
    ³ª¼±±Ù
    [¿¾ ¿ë¾î] ³ª¼±±Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transverse relaxation
    ȾÀÌ¿Ï (üôì¬èÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relaxation
    ÀÌ¿Ï
  • relaxation property
    À̿ϼºÁú
  • relaxation rate
    ÀÌ¿ÏÀ²
  • relaxation state
    À̿ϻóÅÂ
  • relaxation time
    À̿Ͻð£
  • spin lattice relaxation
    ½ºÇɰÝÀÚÀÌ¿Ï
  • spin lattice relaxation time (T1)
    ½ºÇɰÝÀÚÀ̿Ͻð£(T1)
  • spin spin (T2) relaxation
    ½ºÇɽºÇÉÀÌ¿Ï
  • spin spin relaxation
    ½ºÇɽºÇÉÀÌ¿Ï
  • spin spin relaxation time
    ½ºÇɽºÇÉÀ̿Ͻð£
  • T1 (spin lattice) relaxation
    T1(½ºÇɰÝÀÚ)ÀÌ¿Ï
  • T1 relaxation
    T1ÀÌ¿Ï
  • T1 relaxation time
    T1À̿Ͻð£
  • T2 (spin spin) relaxation time
    T2(½ºÇɽºÇÉ)À̿Ͻð£
  • T2 relaxation time
    T2À̿Ͻð£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PML peripheral motor latency; polymorphonuclear leukocyte; posterior mitral leaflet; progressive multifo...
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
SPS scapuloperoneal syndrome; shoulder pain and stiffness; simple partial seizures; slow-progressive sch...
IR drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat...
LR labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IVRT Isovolumic relaxation time
NMRD Nuclear Magnetic Relaxation Dispersion
RARE Rapid Acquisition Relaxation Enhanced
RARE Rapid Acquisition with Relaxation Enhancement
TLESR Transient lower esophageal sphincter relaxation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • T1 relaxation
    T1 ÀÌ¿Ï
  • T2 relaxation time
    T2 ÀÌ¿Ï ½Ã°£
  • T2 spin spin relaxation time
    T2 ½ºÇÉ ½ºÇÉ ÀÌ¿Ï ½Ã°£
  • transverse relaxation time
    ȾÃà ÀÌ¿Ï ½Ã°£
  • chronic progressive disciform granulomatosis
    ¸¸¼º ÁøÇ༺ ¿øÆÇ»ó À°¾ÆÁ¾Áõ
  • familial progressive sensorineural hearing loss
    °¡Á·¼º ÁøÇ༺ °¨°¢ ½Å°æ¼º ³­Ã»
  • juvenile progressive muscular atrophy
    ¿¬¼Ò¼º ÁøÇ༺ ±Ù À§ÃàÁõ
  • progressive
    ÁøÇ༺ÀÇ, Á÷ÁøÀÇ, Á÷Áø¼ºÀÇ
  • progressive bone cyst
    Á¡Áø¼º °ñ ³¶Á¾
  • progressive bulbar palsy
    ÁøÇ༺ ¿¬¼ö ¸¶ºñ
  • progressive cystic swelling
    ÁøÇ༺ ³¶Á¾¼º Á¾Ã¢
  • progressive diaphyseal
    ÁøÇ༺ °ñ°£
  • progressive dystrophic ophthalmoplegia
    ÁøÇ༺ ÀÌ¿µ¾ç¼º ¾È±Ù ¸¶ºñ
  • progressive focal neurologic disturbance
    ÁøÇ༺ ±¹¼ÒÀû ½Å°æÇÐÀû Àå¾Ö
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú ³úº´Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
transverse relaxation In nuclear magnetic resonance, the rapid decay of the nuclear magnetization vector at right angles to the magnetic field after the 90
longitudinal relaxation In nuclear magnetic resonance, the return of the magnetic dipoles of the hydrogen nuclei (magnetization vector) to equilibrium parallel to the magnetic field, after they have been flipped 90
aphasia, primary progressive A type of aphasia appearing gradually and gradually worsening without any major change in other cognitive functions. It is regarded by some authors as a syndrome which may be due to various degenerative diseases of the cerebral cortex (notably alzheimer disease, owing to its frequency), while others see in it an autonomous disease related to a neuropathological process that is distinct from the main degenerative dementias. The principal clinical peculiarity of primary progressive aphasia is that it spares the patient's autonomy for a long time, but ultimately turns into global dementia.
(12 Dec 1998)
bovine progressive degenerative myeloencephalopathy A familiar myeloencephalopathy of brown Swiss cattle characterised by bilateral hindleg weakness and ataxia and deficient proprioceptive reflexes.
(05 Mar 2000)
rapidly progressive glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
chronic progressive chorea A progressive disorder usually beginning in young to middle age, consisting of a triad of choreoathetosis, dementia, and autosomal dominant inheritance with complete penetrance. Bilateral marked wasting of the putamen and the head of the caudate nucleus is characteristic.
Synonym: chronic progressive chorea, degenerative chorea, hereditary chorea, Huntington's disease.
(05 Mar 2000)
chronic progressive external ophthalmoplegia A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
chronic progressive syphilitic meningoencephalitis Syphilitic infection manifested as dementia (often with delusional features), dysarthria, seizures, myoclonic jerks, action tremor, impaired walking and standing, pupillary abnormalities, and abnormal CSF findings.
Synonym: chronic progressive syphilitic meningoencephalitis.
(05 Mar 2000)
pneumonia, progressive interstitial, of sheep Chronic respiratory disease caused by the visna-maedi virus. It was formerly believed to be identical with jaagsiekte (pulmonary adenomatosis, ovine) but is now recognised as a separate entity.
(12 Dec 1998)
primary progressive cerebellar degeneration A familial ataxic condition related to cerebellar degeneration.
(05 Mar 2000)
progressive Advancing, going forward, going from bad to worse, increasing in scope or severity.
(18 Nov 1997)
progressive bacterial synergistic gangrene Undermining ulcer of the skin and subcutaneous tissues, usually following an operation, caused by a synergistic interaction between microaerophilic nonhemolytic streptococci and aerobic haemolytic staphylococci.
Synonym: Meleney's gangrene, progressive bacterial synergistic gangrene.
(05 Mar 2000)
progressive bulbar palsy One of the subgroups of motor neuron disease; a progressive degenerative disorder of the motor neurons of primarily the brainstem, manifested as weakness (and wasting) of the various bulbar muscles, resulting in dysarthria and dysphagia-fluid regurgitation is an outstanding symptom and can cause aspiration; tongue weakness and wasting is usually evident, and often the fasciculation potentials are present in the tongue and facial muscles.
Synonym: glossopalatolabial paralysis, glossopharyngeolabial paralysis.
(05 Mar 2000)
progressive bulbar paralysis Progressive weakness and atrophy of the muscles of the tongue, lips, palate, pharynx, and larynx, usually occurring in later life; most often caused by motor neuron disease.
Synonym: bulbar palsy, bulbar paralysis, Duchenne's disease, Erb disease, glossolabiolaryngeal paralysis, glossolabiopharyngeal paralysis.
(05 Mar 2000)
progressive cataract A cataract in which the opacification process progresses to involve the entire lens.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive proof
    (»öÀÇ) ´Ü°èº° ±³Á¤¼â
  • progressive rock
    ÇÁ·Î±×·¹½Ãºê ·Ï
  • progressive soul
    ÇÁ·Î±×·¹½Ãºê ¼Ò¿ï
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á